06/2010
Retinoblastoma is the prototype genetic cancer caused by mutations disrupting the RB1 tumor suppressor gene. Following loss of RB1, retinoblastoma acquires...
MYCN | Genetics | Retinoblastoma | aCGH
MYCN | Genetics | Retinoblastoma | aCGH
Dissertation
Reproductive BioMedicine Online, ISSN 1472-6483, 08/2019, Volume 39, pp. e45 - e46
Journal Article
Journal Article
Seizure, ISSN 1059-1311, 01/2018, Volume 54, pp. 41 - 44
Purpose GLUT1-deficiency syndrome (GLUT1-DS) is a metabolic brain disorder with a great clinical heterogeneity underlined by various mutations in the SLC2A1...
GLUT1-DS | SLC2A1 mutations | aCGH analysis
GLUT1-DS | SLC2A1 mutations | aCGH analysis
Journal Article
5.
Full Text
IMPACT OF INTRODUCTION OF NIPT ON UPTAKE OF GENETIC TESTING IN FETUSES WITH CNS ANOMALIES
Journal of Obstetrics and Gynaecology Canada, ISSN 1701-2163, 05/2019, Volume 41, Issue 5, pp. 708 - 708
Journal Article
Genetics in Medicine, ISSN 1098-3600, 07/2009, Volume 11, Issue 7, pp. 518 - 526
Journal Article
Biotechnology & Biotechnological Equipment, ISSN 1310-2818, 01/2019, Volume 33, Issue 1, pp. 1663 - 1670
Preimplantation genetic testing (PGT) is presently the only option available for detecting genetic conditions in embryos created through in vitro fertilization...
translocations | PGT | complex chromosomal rearrangements | aCGH
translocations | PGT | complex chromosomal rearrangements | aCGH
Journal Article
Clinical and Experimental Obstetrics and Gynecology, ISSN 0390-6663, 2018, Volume 45, Issue 5, pp. 797 - 799
Journal Article
The Oncologist, ISSN 1083-7159, 03/2019, Volume 24, Issue 3, pp. 327 - 337
Background The randomized phase III study (WJOG4407G) showed equivalent efficacy between FOLFOX and FOLFIRI in combination with bevacizumab as the first‐line...
Irinotecan | Oxaliplatin | aCGH analysis | Colorectal cancer | Bevacizumab | MIR29 | EFFICACY | ONCOLOGY | MYC | GENES
Irinotecan | Oxaliplatin | aCGH analysis | Colorectal cancer | Bevacizumab | MIR29 | EFFICACY | ONCOLOGY | MYC | GENES
Journal Article
BMC medical genomics, 12/2018, Volume 11, Issue 1, p. 124
Journal Article
Current Genomics, ISSN 1389-2029, 2018, Volume 19, Issue 6, pp. 499 - 504
Journal Article
The American Journal of Human Genetics, ISSN 0002-9297, 08/2014, Volume 95, Issue 2, pp. 173 - 182
New human mutations are thought to originate in germ cells, thus making a recurrence of the same mutation in a sibling exceedingly rare. However, increasing...
ORIGIN | MUTATION | GENETICS & HEREDITY | DETECTABLE CLONAL MOSAICISM | ACGH | AGE | DELETION | Recurrence | Gametogenesis - genetics | Prospective Studies | Genomics | Humans | Genetic Diseases, Inborn - genetics | Male | Risk | DNA Copy Number Variations - genetics | Sex Characteristics | Germ-Line Mutation - genetics | Smith-Magenis Syndrome - genetics | Pedigree | Cell Division | Female | Mosaicism | Germ Cells - cytology | Models, Genetic | Mutation | Research | Gene mutations | Analysis
ORIGIN | MUTATION | GENETICS & HEREDITY | DETECTABLE CLONAL MOSAICISM | ACGH | AGE | DELETION | Recurrence | Gametogenesis - genetics | Prospective Studies | Genomics | Humans | Genetic Diseases, Inborn - genetics | Male | Risk | DNA Copy Number Variations - genetics | Sex Characteristics | Germ-Line Mutation - genetics | Smith-Magenis Syndrome - genetics | Pedigree | Cell Division | Female | Mosaicism | Germ Cells - cytology | Models, Genetic | Mutation | Research | Gene mutations | Analysis
Journal Article
Clinical cancer research : an official journal of the American Association for Cancer Research, ISSN 1078-0432, 6/2010, Volume 16, Issue 11, pp. 2971 - 2978
Journal Article
Leukemia and Lymphoma, ISSN 1042-8194, 08/2011, Volume 52, Issue 8, pp. 1567 - 1573
Journal Article
Genomics, ISSN 0888-7543, 2011, Volume 97, Issue 3, pp. 158 - 165
We carried out a cross species cattle–sheep array comparative genome hybridization experiment to identify copy number variations (CNVs) in the sheep genome...
Sheep breeds | Copy number variation | Ovis aries | Comparative map | aCGH | Ruminants | ACGH | LINKAGE MAP | DNA-SEQUENCES | DIFFERENT COAT COLORS | RADIATION HYBRID PANEL | MAJOR HISTOCOMPATIBILITY COMPLEX | ARRAY CGH DATA | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SIGNALING PROTEIN ASIP | GENETICS & HEREDITY | GENE-EXPRESSION | FAMILY BOVIDAE | STRUCTURAL VARIATION | Animals | Oligonucleotide Array Sequence Analysis | Cattle | Chromosomes - genetics | Chromosome Mapping | DNA Copy Number Variations - genetics | Comparative Genomic Hybridization - methods | Genome | Sheep - genetics | Comparative analysis | Sheep | Genomics | DNA microarrays | Dairies | DNA probes | copy number | Chromosomes
Sheep breeds | Copy number variation | Ovis aries | Comparative map | aCGH | Ruminants | ACGH | LINKAGE MAP | DNA-SEQUENCES | DIFFERENT COAT COLORS | RADIATION HYBRID PANEL | MAJOR HISTOCOMPATIBILITY COMPLEX | ARRAY CGH DATA | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SIGNALING PROTEIN ASIP | GENETICS & HEREDITY | GENE-EXPRESSION | FAMILY BOVIDAE | STRUCTURAL VARIATION | Animals | Oligonucleotide Array Sequence Analysis | Cattle | Chromosomes - genetics | Chromosome Mapping | DNA Copy Number Variations - genetics | Comparative Genomic Hybridization - methods | Genome | Sheep - genetics | Comparative analysis | Sheep | Genomics | DNA microarrays | Dairies | DNA probes | copy number | Chromosomes
Journal Article
16.
Full Text
16p13.11 duplication is a risk factor for a wide spectrum of neuropsychiatric disorders
Journal of Human Genetics, ISSN 1434-5161, 07/2011, Volume 56, Issue 7, pp. 541 - 544
The chromosome 16p13.11 heterozygous deletion is associated with a diverse array of neuropsychiatric disorders including intellectual disabilities, autism,...
neuropsychiatric disorders | deletion | chromosome 16p13.11 | duplication; microarray-based comparative genomic hybridization (aCGH) | MICRODELETION | AUTISM | VARIANTS | RARE CHROMOSOMAL DELETIONS | SCHIZOPHRENIA | duplication | DISEASE | GENETICS & HEREDITY | microarray-based comparative genomic hybridization (aCGH) | COMPARATIVE GENOMIC HYBRIDIZATION | PREDISPOSE | ARRAY CGH | CEREBRAL CORTICAL SIZE | Autistic Disorder - genetics | Gene Duplication | Sequence Deletion | Seizures - genetics | Comparative Genomic Hybridization | Humans | Risk Factors | Developmental Disabilities - genetics | Abnormalities, Multiple - genetics | Chromosomes, Human, Pair 16 - genetics
neuropsychiatric disorders | deletion | chromosome 16p13.11 | duplication; microarray-based comparative genomic hybridization (aCGH) | MICRODELETION | AUTISM | VARIANTS | RARE CHROMOSOMAL DELETIONS | SCHIZOPHRENIA | duplication | DISEASE | GENETICS & HEREDITY | microarray-based comparative genomic hybridization (aCGH) | COMPARATIVE GENOMIC HYBRIDIZATION | PREDISPOSE | ARRAY CGH | CEREBRAL CORTICAL SIZE | Autistic Disorder - genetics | Gene Duplication | Sequence Deletion | Seizures - genetics | Comparative Genomic Hybridization | Humans | Risk Factors | Developmental Disabilities - genetics | Abnormalities, Multiple - genetics | Chromosomes, Human, Pair 16 - genetics
Journal Article
Genetics in Medicine, ISSN 1098-3600, 07/2011, Volume 13, Issue 7, pp. 680 - 685
Genomic microarrays used to assess DNA copy number are now recommended as first-tier tests for the postnatal evaluation of individuals with intellectual...
copy number variant | microarray | CNV | CMA | aCGH | MICRODELETION | DIAGNOSIS | INTERSTITIAL DELETION | CHROMOSOME | HUMAN GENOME | DISEASE | GENETICS & HEREDITY | MUTATIONS | SCALE | STRUCTURAL VARIATION | Autistic Disorder - genetics | Microarray Analysis - methods | Clinical Laboratory Techniques - statistics & numerical data | Gene Dosage - genetics | Genetics, Medical - methods | Genetics, Medical - standards | Humans | Developmental Disabilities - genetics | Clinical Laboratory Techniques - standards | Microarray Analysis - statistics & numerical data | Genetics, Medical - statistics & numerical data | Genome, Human - genetics | Intellectual Disability - genetics | Genetic Variation | Clinical Laboratory Techniques - methods | Abnormalities, Multiple - diagnosis | Intellectual Disability - diagnosis | Microarray Analysis - standards | Autistic Disorder - diagnosis | Child | Developmental Disabilities - diagnosis | Abnormalities, Multiple - genetics | Autism | genomics | Genomes | copy number | Congenital defects | Mental retardation
copy number variant | microarray | CNV | CMA | aCGH | MICRODELETION | DIAGNOSIS | INTERSTITIAL DELETION | CHROMOSOME | HUMAN GENOME | DISEASE | GENETICS & HEREDITY | MUTATIONS | SCALE | STRUCTURAL VARIATION | Autistic Disorder - genetics | Microarray Analysis - methods | Clinical Laboratory Techniques - statistics & numerical data | Gene Dosage - genetics | Genetics, Medical - methods | Genetics, Medical - standards | Humans | Developmental Disabilities - genetics | Clinical Laboratory Techniques - standards | Microarray Analysis - statistics & numerical data | Genetics, Medical - statistics & numerical data | Genome, Human - genetics | Intellectual Disability - genetics | Genetic Variation | Clinical Laboratory Techniques - methods | Abnormalities, Multiple - diagnosis | Intellectual Disability - diagnosis | Microarray Analysis - standards | Autistic Disorder - diagnosis | Child | Developmental Disabilities - diagnosis | Abnormalities, Multiple - genetics | Autism | genomics | Genomes | copy number | Congenital defects | Mental retardation
Journal Article
British Journal of Haematology, ISSN 0007-1048, 02/2016, Volume 172, Issue 3, pp. 428 - 438
Summary The introduction of Rituximab has improved the outcome and survival rates of Burkitt lymphoma (BL). However, early relapse and refractoriness are...
rituximab | next‐generation sequencing | outcome | Burkitt lymphoma | array‐based comparative genomic hybridization (aCGH) | Rituximab | Next-generation sequencing | Outcome | Array-based comparative genomic hybridization (aCGH) | SURVIVAL | next-generation sequencing | ABNORMALITIES | FOLLICULAR LYMPHOMA | HYBRIDIZATION | TP53 MUTATIONS | CHROMOSOMAL ALTERATIONS | array-based comparative genomic hybridization (aCGH) | B-CELL LYMPHOMA | HIGH-RESOLUTION | NON-HODGKINS-LYMPHOMA | HEMATOLOGY | EXPRESSION | Prognosis | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Treatment Outcome | Comparative Genomic Hybridization - methods | Rituximab - administration & dosage | Young Adult | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Chromosome Aberrations | Burkitt Lymphoma - genetics | Adult | Female | Aged | Genome | High-Throughput Nucleotide Sequencing - methods | Burkitt Lymphoma - drug therapy | Antimitotic agents | Care and treatment | Chemotherapy | Patient outcomes | Analysis | Cytogenetics | Genetic aspects | Tumor proteins | Antineoplastic agents | Burkitt's lymphoma | Cancer
rituximab | next‐generation sequencing | outcome | Burkitt lymphoma | array‐based comparative genomic hybridization (aCGH) | Rituximab | Next-generation sequencing | Outcome | Array-based comparative genomic hybridization (aCGH) | SURVIVAL | next-generation sequencing | ABNORMALITIES | FOLLICULAR LYMPHOMA | HYBRIDIZATION | TP53 MUTATIONS | CHROMOSOMAL ALTERATIONS | array-based comparative genomic hybridization (aCGH) | B-CELL LYMPHOMA | HIGH-RESOLUTION | NON-HODGKINS-LYMPHOMA | HEMATOLOGY | EXPRESSION | Prognosis | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Treatment Outcome | Comparative Genomic Hybridization - methods | Rituximab - administration & dosage | Young Adult | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Chromosome Aberrations | Burkitt Lymphoma - genetics | Adult | Female | Aged | Genome | High-Throughput Nucleotide Sequencing - methods | Burkitt Lymphoma - drug therapy | Antimitotic agents | Care and treatment | Chemotherapy | Patient outcomes | Analysis | Cytogenetics | Genetic aspects | Tumor proteins | Antineoplastic agents | Burkitt's lymphoma | Cancer
Journal Article
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, ISSN 1426-9686, 04/2016, Volume 40, Issue 238, pp. 255 - 259
Journal Article
Pediatrics, ISSN 0031-4005, 04/2010, Volume 125, Issue 4, pp. e727 - e735
BACKGROUND: Multiple lines of evidence indicate a strong genetic contribution to autism spectrum disorders (ASDs). Current guidelines for clinical genetic...
Microdeletion | ASD | Neuropsychiatric disorders | Language delay | Array CGH | ACGH | Autism spectrum disorder | Microduplication | array CGH | MENTAL-RETARDATION | MICROARRAY | microdeletion | FISH ANALYSIS | IMBALANCES | aCGH | PERVASIVE DEVELOPMENTAL DISORDERS | CHROMOSOMAL REARRANGEMENTS | CHILDREN | language delay | microduplication | COPY-NUMBER | ARRAY-CGH | neuropsychiatric disorders | PEDIATRICS | autism spectrum disorder | COMPARATIVE GENOMIC HYBRIDIZATION | Microarray Analysis - methods | Humans | Child, Preschool | Infant | Male | Genetic Testing - methods | Karyotyping - methods | Young Adult | Child Development Disorders, Pervasive - genetics | Adolescent | Child Development Disorders, Pervasive - diagnosis | Female | Child | Cohort Studies | Autism | Genetic testing | Clinical medicine | Patients | Chromosomes | Deoxyribonucleic acid--DNA
Microdeletion | ASD | Neuropsychiatric disorders | Language delay | Array CGH | ACGH | Autism spectrum disorder | Microduplication | array CGH | MENTAL-RETARDATION | MICROARRAY | microdeletion | FISH ANALYSIS | IMBALANCES | aCGH | PERVASIVE DEVELOPMENTAL DISORDERS | CHROMOSOMAL REARRANGEMENTS | CHILDREN | language delay | microduplication | COPY-NUMBER | ARRAY-CGH | neuropsychiatric disorders | PEDIATRICS | autism spectrum disorder | COMPARATIVE GENOMIC HYBRIDIZATION | Microarray Analysis - methods | Humans | Child, Preschool | Infant | Male | Genetic Testing - methods | Karyotyping - methods | Young Adult | Child Development Disorders, Pervasive - genetics | Adolescent | Child Development Disorders, Pervasive - diagnosis | Female | Child | Cohort Studies | Autism | Genetic testing | Clinical medicine | Patients | Chromosomes | Deoxyribonucleic acid--DNA
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.